Irinotecan plus carboplatin versus etoposide plus carboplatin in extensive disease small cell lung cancer: Results of the German randomized phase III trial

被引：0
|
作者：
Schmittel, A. H. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Sebastian, M. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
von Weikersthal, L. Fischer [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Gauler, T. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Hortig, P. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Fischer, J. R. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Link, H. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Binder, D. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Eberhardt, W. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Keilholz, U. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
机构：
[1] Charite, Campus Benjamin Franklin, Berlin, Germany
[2] 3rd Med Clin, Mainz, Germany
[3] MVZ Gesundheitsztr St Marien, Amberg, Germany
[4] W German Canc Ctr, Essen, Germany
[5] Charite Campus Benjamin Franklin, Berlin, Germany
[6] Klinikum Lowenstein, Lowenstein, Germany
[7] Westpfalz Kliniken, Kaiserslautern, Germany
[8] Charite Campus Virchow, Berlin, Germany
[9] W German Canc Ctr, Essen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8029
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer:: A Randomized phase III trial
    Hermes, Andreas
    Bergman, Bengt
    Bremnes, Roy
    Ek, Lars
    Fluge, Sverre
    Sederholm, Christer
    Sundstrom, Stein
    Thaning, Lars
    Vilsvik, Jan
    Aasebo, Ulf
    Soerenson, Sverre
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) : 4261 - 4267
  • [2] A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin in patients with extensive disease small cell lung cancer
    Schmittel, A.
    Fischer von Weikersthal, L.
    Sebastian, M.
    Schulze, K.
    Link, H.
    Thiel, E.
    Keilholz, U.
    EJC SUPPLEMENTS, 2005, 3 (02): : 327 - 328
  • [3] Irinotecan plus carboplatin versus etoposide plus carboplatin in extensive disease small cell lung cancer: A randomized phase II trial.
    Schmittel, A
    von Weikersthal, LF
    Sebastian, M
    Link, H
    Schulze, K
    Thiel, E
    Keilhoz, U
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 632S - 632S
  • [4] A randomized phase III trial of irinotecan plus carboplatin versus etoposide plus carboplatin in patients with small cell lung cancer, extensive disease (SCLC-ED): IRIS-Study
    Hermes, A.
    Bergman, B.
    Bremnes, R.
    Ek, L.
    Fluge, S.
    Sederholm, C.
    Sundstrom, S.
    Thaning, L.
    Vilsvik, J.
    Aasebo, U.
    Sorenson, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancer
    Schmittel, A
    von Weikersthal, LF
    Sebastian, M
    Martus, P
    Schulze, K
    Hortig, P
    Reeb, M
    Thiel, E
    Keilholz, U
    ANNALS OF ONCOLOGY, 2006, 17 (04) : 663 - 667
  • [6] Irinotecan, carboplatin and etoposide regimen in extensive disease small cell lung cancer: Phase II trial
    Syrigos, K.
    Katirtzoglou, N.
    Charpidou, A.
    Botsis, T.
    Karapanagiotou, E.
    Dilana, K.
    Gkiozos, I.
    Pantazopoulos, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer
    Reck, M
    von Pawel, J
    Macha, HN
    Kaukel, E
    Deppermann, KM
    Bonnet, R
    Ulm, K
    Hessler, S
    Gatzemeier, U
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (15) : 1118 - 1127
  • [8] Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer
    Kim, Young Saing
    Park, Se Hoon
    Kyung, Sun Young
    Sym, Sun Jin
    Lee, Sang Pyo
    Park, Jeong Woong
    Jung, Sung Hwan
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Shin, Dong Bok
    MEDICAL ONCOLOGY, 2011, 28 (01) : 342 - 350
  • [9] Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer
    Young Saing Kim
    Se Hoon Park
    Sun Young Kyung
    Sun Jin Sym
    Sang Pyo Lee
    Jeong Woong Park
    Sung Hwan Jung
    Jinny Park
    Eun Kyung Cho
    Jae Hoon Lee
    Dong Bok Shin
    Medical Oncology, 2011, 28 : 342 - 350
  • [10] A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancer
    Schmittel, A.
    Sebastian, M.
    von Weikersthal, L. Fischer
    Martus, P.
    Gauler, T. C.
    Kaufmann, C.
    Hortig, P.
    Fischer, J. R.
    Link, H.
    Binder, D.
    Fischer, B.
    Caca, K.
    Eberhardt, W. E. E.
    Keilholz, U.
    ANNALS OF ONCOLOGY, 2011, 22 (08) : 1798 - 1804
12345